Mystic Asset Management, Inc. Inhibikase Therapeutics, Inc. Transaction History

Mystic Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 11, 2022	SELL	$1.03 - $1.77 $2,343 - $4,026	-2,275 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$1.38 - $2.17 $3,139 - $4,936	2,275 New	2,275 $3,000

1.03M

Ticker IKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,227,100
Market Cap $33.8M
Description
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...

Get notified when there are updates to the investment portfolio of Mystic Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mystic Asset Management, Inc. with notifications on news.